CATX Similar Chart Price Prediction
The price of CATX is predicted to go up 13.7%, based on the high correlation periods with ELA. The similarity of these two price pattern on the periods is 98.29%.
CATX
ELA
Up: 13.7%Similarity: 98.29%
CATX Revenue Forecast
CATX EPS Forecast
CATX FAQs
What is CATX revenue forecast for next quarter？
CATX Analyst's Forecast
Gregory Renza
RBC Capital
Buy
2024-11-25
Price Target
$25 → $16
Upside
+264.46%
RBC Capital lowered the firm's price target on Perspective Therapeutics to $16 from $25 and keeps an Outperform rating on the shares. Initial data from Cohort 1 and Cohort 2 of VMT-a-NET's phase I/IIa study highlights encouraging signals, but also a need for patience for dose optimization, the analyst tells investors in a research note. The firm sees a path to potential commerciality from Perspective's lead-specific chelator across its pipeline and platform.
Jeff Jones
Oppenheimer
Buy
2024-11-22
Price Target
$22 → $16
Upside
+357.14%
David Dai
UBS
Strong Buy
2024-10-24
Price Target
$20
Upside
+68.21%
